Of note are the observations that linagliptin significantly improved hypoglycemia in klotho−/− mice, as shown by the findings of OGTT and significantly increased non-fasting blood glucose levels, while linagliptin did not affect serum insulin levels of klotho−/− mice. This evidence concerns the gene INS and Hypoglycemia.